Year archive

China NT Pharma Group Company Limited — 2017 filings

All 47 regulatory filings released by China NT Pharma Group Company Limited (1011) in 2017, sourced directly from the official regulator.

47 Filings

2017 Period

2017 filings (47)

Filing	Released	Lang
INSIDE INFORMATION TERMINATION OF SALES AND PROMOTION AGREEMENT Regulatory Filings	2017-12-15	English
Monthly Return of Equity Issuer on Movements in Securities For the month ended 30 November 2017 Regulatory Filings	2017-12-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2017 Regulatory Filings	2017-11-01	English
COMPLETION OF MAJOR TRANSACTION IN RELATION TO THE ACQUISITION OF MIACALCIC SPRAY IN CHINA AND IN OTHER TERRITORIES M&A Activity	2017-10-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2017 Share Issue/Capital Change	2017-10-03	English
Interim Report 2017 Interim / Quarterly Report H1 2017	2017-09-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2017 Capital/Financing Update	2017-09-04	English
VOLUNTARY ANNOUNCEMENT SUCCESSFUL BIDDING OF XI DI KE AS A PRODUCT IN HUBEI PROVINCE'S MEDICINE CATALOGUE FOR MEDICAL INSURANCE Regulatory Filings	2017-08-29	English
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING IN THE COMPANY BY THE CONTROLLING SHAREHOLDER Major Shareholding Notification	2017-08-24	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2017 Interim / Quarterly Report H1 2017	2017-08-21	English
NOTICE OF BOARD MEETING Regulatory Filings	2017-08-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2017 Regulatory Filings	2017-08-02	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2017-07-31	English
APPOINTMENT AND RESIGNATION OF NON-EXECUTIVE DIRECTOR Board/Management Information	2017-07-31	English
POSITIVE PROFIT ALERT Regulatory Filings	2017-07-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2017 Share Issue/Capital Change	2017-07-07	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2017-06-29	English
APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE OF MEMBER OF BOARD COMMITTEES Board/Management Information	2017-06-29	English
Next Day Disclosure Return Share Issue/Capital Change	2017-06-14	English
COMPLETION OF THE ISSUE OF CONVERTIBLE PREFERENCE SHARES Capital/Financing Update	2017-06-14	English
VOLUNTARY ANNOUNCEMENT THE PROJECT ON A NEW INDICATION OF NATIONAL CLASS 1.1 NEW DRUG XI DI KE RECEIVED SPECIAL SUPPORT FROM THE MINISTRY OF SCIENCE AND TECHNOLOGY, THE NATIONAL HEALTH AND FAMILY PLA Regulatory Filings	2017-06-09	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities For the month ended 31 May 2017 Regulatory Filings	2017-06-06	English
1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 5 JUNE 2017; AND 2) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 5 JUNE 2017 Declaration of Voting Results & Voting Rights Announcements	2017-06-05	English
Monthly Return of Equity Issuer on Movements in Securities For the month ended 31 May 2017 Capital/Financing Update	2017-06-05	English
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING IN THE COMPANY BY THE CONTROLLING SHAREHOLDER Major Shareholding Notification	2017-05-29	English
FORM OF PROXY FOR USE AT EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2017-05-12	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2017-05-12	English
(1) PROPOSED ISSUE OF CONVERTIBLE PREFERENCE SHARES (2) PROPOSED GRANT OF SPECIFIC MANDATE TO ISSUE CONVERTIBLE PREFERENCE SHARES AND CONVERSION SHARES (3) PROPOSED RE-DESIGNATION OF AUTHORISED SHA Proxy Solicitation & Information Statement	2017-05-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2017 Share Issue/Capital Change	2017-05-05	English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2017-04-27	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2017-04-27	English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES AND PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING AGM Information	2017-04-27	English
Annual Report 2016 Annual Report FY 2016	2017-04-27	English
CHANGE OF NAME OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE IN THE CAYMAN ISLANDS Regulatory Filings	2017-04-21	English
SUPPLEMENTAL AGREEMENT IN RELATION TO PROPOSED ISSUANCE OF CONVERTIBLE PREFERENCE SHARES Capital/Financing Update	2017-04-21	English
(1) PROPOSED ISSUE OF CONVERTIBLE PREFERENCE SHARES (2) PROPOSED GRANT OF SPECIFIC MANDATE TO ISSUE CONVERTIBLE PREFERENCE SHARES AND CONVERSION SHARES AND (3) PROPOSED RE-DESIGNATION OF AUTHOR Capital/Financing Update	2017-04-20	English
(1) PROPOSED ISSUE OF CONVERTIBLE PREFERENCE SHARES (2) PROPOSED GRANT OF SPECIFIC MANDATE TO ISSUE CONVERTIBLE PREFERENCE SHARES AND CONVERSION SHARES AND (3) PROPOSED RE-DESIGNATION OF AUTHOR Capital/Financing Update	2017-04-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2017 Regulatory Filings	2017-04-06	English
VOLUNTARY ANNOUNCEMENT POTENTIAL ISSUANCE OF REDEEMABLE CONVERTIBLE PREFERENCE SHARES Capital/Financing Update	2017-03-22	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2016 Annual Report FY 2016	2017-03-21	English
NOTICE OF BOARD MEETING Regulatory Filings	2017-03-06	English
VOLUNTARY ANNOUNCEMENT NT BIOPHARMA OBTAINED NEW GMP CERTIFICATION FROM CFDA PRODUCTION AND SALES OF NATIONAL CLASS 1.1 NEW DRUG "XI DI KE" WILL OFFICIALLY COMMENCE Regulatory Filings	2017-03-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2017 Regulatory Filings	2017-03-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2017 Share Issue/Capital Change	2017-02-06	English
Monthly Return of Equity Issuer on Movements in Securities For the month ended 31 December 2016 Capital/Financing Update	2017-01-04	English
ANNOUNCEMENT OF APPROVAL OF XI DI KE, NATIONAL CLASS 1.1 NEW DRUG TO ENTER THE MARKET Regulatory Filings	2017-01-04	English
ANNOUNCEMENT OF APPROVAL OF XI DI KE, NATIONAL CLASS 1.1 NEW DRUG TO ENTER THE MARKET Regulatory Filings	2017-01-04	English

Filings by year

2026 31 filings
2025 67 filings
2024 53 filings
2023 41 filings
2022 46 filings
2021 31 filings
2020 54 filings
2019 61 filings
2018 46 filings
2017 47 filings
2016 42 filings
2015 53 filings
2014 39 filings
2013 37 filings
2012 45 filings
2011 25 filings